Clinical evaluation of hip joint diseases: total hip arthroplasty to support patients’ quality of life

Yamate, Satoshi; Hamai, Satoshi; Lyman, Stephen; Konishi, Toshiki; Kawahara, Shinya; Yamaguchi, Ryosuke; Hara, Daisuke; Motomura, Goro

doi:10.1016/j.jjoisr.2022.12.004

Cited by 7 publications

(4 citation statements)

References 77 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2010, Jingushi et al 1 reported that the mean age of new patients with hip OA was 58 years and that patients in their 50s constituted the age group with the most patients. In the present study, the mean patient age was 63.5 years and patients in their 70s made up the largest age group; the increase in age among patients in our study is consistent with the aging population in Japan 44 . Our findings indicate that the prevalence of secondary hip OA due to hip dysplasia decreased from 81% 1 to 73.8%; this change could be explained by the increasing number of patients in their 70s and 80s with primary OA and SIF.…”

Section: Discussionsupporting

confidence: 88%

Life Course Epidemiology of Hip Osteoarthritis in Japan

Sato,

Yamate,

Utsunomiya

et al. 2024

Journal of Bone and Joint Surgery

Self Cite

View full text Add to dashboard Cite

Background: The incidence of developmental dysplasia of the hip (DDH) in Japanese newborns has reduced drastically following a primary prevention campaign initiated around 1972 to 1973; this perinatal education campaign promoted maintaining the hips of newborns in the naturally flexed-leg position. The purpose of the present study was to describe the life course epidemiology of hip osteoarthritis (OA) in adolescent and adult patients and to assess its association with exposure to the primary prevention campaign for DDH. Methods: We included new patients with hip OA diagnosed from January 1, 2022, to December 31, 2022, at 12 core hospitals (8 special-function hospitals and 4 regional medical care support hospitals). The trend in the percentage of hips with a history of DDH treatment in childhood was estimated with use of a centered moving average using the birth year of the patient. We compared the prevalence of severe subluxation (Crowe type II, III, or IV) between patients with secondary hip OA due to hip dysplasia who were born in or before 1972 and those who were born in or after 1973. Results: Overall, 1,095 patients (1,381 hips) were included. The mean age at the time of the survey was 63.5 years (range, 15 to 95 years). A total of 795 patients (1,019 hips; 73.8% of hips) were diagnosed with secondary OA due to hip dysplasia. Approximately 13% to 15% of hips among patients born from 1963 to 1972 had a history of DDH treatment in childhood; however, the percentage decreased among patients born in or after 1973. The prevalence of severe subluxation (Crowe type II, III, or IV) among patients born in or after 1973 was 2.4%, which was significantly less than that among patients born in or before 1972 (11.1%; odds ratio, 0.20; p < 0.001). Conclusions: As of 2022, secondary hip OA due to hip dysplasia is still responsible for most new cases of adolescent and adult hip OA seen in core hospitals in Japan. However, the perinatal education campaign initiated 50 years ago, which utilized a population approach and advocated for maintaining the hips of newborns in the naturally flexed-leg position, may have improved the environmental factors of DDH, as indicated by the apparently reduced need for treatment of DDH in childhood and the associated severe subluxation. This may result in a reduced need for challenging hip surgery later in life. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

show abstract

Section: Discussionsupporting

confidence: 88%

Life Course Epidemiology of Hip Osteoarthritis in Japan

Sato,

Yamate,

Utsunomiya

et al. 2024

Journal of Bone and Joint Surgery

Self Cite

View full text Add to dashboard Cite

show abstract

“…The Forgotten Joint Score (FJS)-12 is a 12-item questionnaire for the assessment of joint awareness in daily life after arthroplasty [31][32][33]. The answers to 12 items concerning the frequency of joint awareness (never, 0 point; almost never, 1 point; seldom, 2 points; sometimes, 3 points; mostly, 4 points) are summed and converted into a 100-point scale, with higher scores indicating better outcomes.…”

Section: Questionnairesmentioning

confidence: 99%

Interaction between physical activity and sleep quality at midterm after total knee arthroplasty: a Japanese retrospective cohort study

Hamai

Harada

Tsushima

et al. 2023

Preprint

Self Cite

View full text Add to dashboard Cite

Purpose No report has clarified the frequency and interacting factors affecting sleep disturbance among Asian patients at midterm after total knee arthroplasty (TKA). This study aimed to evaluate the frequency of sleep disturbance at midterm after TKA in a Japanese cohort and to identify intervening factors for sleep. We hypothesized that residual knee pain and decreased physical activity negatively interact with sleep quality after TKA.Methods A total of 209 Japanese participants (average age: 77.1 ± 8.3 years; postoperative follow-up period: 4.5 ± 1.9 years) who underwent primary TKA for knee osteoarthritis were included in this study. Sleep quality, satisfaction, pain, physical activity, joint awareness, and mental condition were evaluated using the Pittsburgh Sleep Quality Index (PSQI), Knee Society Score (KSS) 2011, Forgotten Joint Score (FJS)-12, and 12-Item Short-Form Health Survey (SF-12) Mental Component Summary (MCS). Multivariate analysis was performed to determine the influencing factors on PSQI.Results The scores for the PSQI, satisfaction with pain level while lying in bed, pain during level walking, functional activity category in the KSS 2011, awareness of the artificial joint in bed at night in the FJS-12, and SF-12 MCS were 6.7 ± 3.0, 5.8 ± 1.8, 1.6 ± 2.3, 62 ± 22, 1.5 ± 1.4, and 56 ± 9.3 on average, respectively. Sleep disturbance (PSQI ≥ 5.5) occurred in 54% of the Japanese participants. Multivariate analysis revealed that high activity was a significant interacting factor for sleep quality improvement (p < .05).Conclusion Decreased physical activity, not residual knee pain, negatively interacted with sleep quality. The sleep disturbance rate was high during the middle postoperative period after TKA in the Japanese cohort, suggesting that interventions that promote daytime exercises may be effective.

show abstract

“…The prevention of NSAID-induced ulcers can be established from the initial prescription of NSAIDs, such as in an orthopaedic outpatient clinic; however, several of these prescriptions fail to adhere to the guidelines for preventing ulcers [ 22 ]. In our study, we focused on new users of NSAIDs with low back pain or joint pain caused by osteoarthritis, which are typical orthopaedic diseases [ 23 – 26 ], to evaluate the effectiveness of co-prescription of rebamipide in preventing NSAID-induced ulcers. Our investigation aimed to answer the question, “Does rebamipide contribute to preventing upper gastrointestinal bleeding in new users of NSAIDs for osteoarthritis or low back pain and who are at low risk of NSAID-induced ulcers?” We hypothesized that continuous co-prescription of rebamipide would have a preventive effect on NSAID-induced ulcers.…”

Section: Introductionmentioning

confidence: 99%

Continuous co-prescription of rebamipide prevents upper gastrointestinal bleeding in NSAID use for orthopaedic conditions: A nested case-control study using the LIFE Study database

Yamate,

Ishiguro,

Fukuda

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

Background Rebamipide has been widely co-prescribed with non-steroidal anti-inflammatory drugs (NSAIDs) in Japan for decades. This study aimed to evaluate the effectiveness of rebamipide in preventing upper gastrointestinal bleeding in new users of NSAIDs without risk factors of NSAID-induced ulcers other than age. Methods A nested case-control study was conducted using medical claims data of 1.66 million inhabitants of 17 municipalities participating in Japan’s Longevity Improvement & Fair Evidence study. The cohort entry (t0) corresponded to a new user of NSAIDs for osteoarthritis or low back pain. Patients with risk factors of NSAID-induced ulcers other than age were excluded. Cases were defined as patients who underwent gastroscopy for upper gastrointestinal bleeding (occurrence date was defined as index date). A maximum of 10 controls were selected from non-cases at the index date of each case by matching sex, age, follow-up time, and type and dosage of NSAIDs. Exposure to rebamipide was defined as prescription status from t0 to index date: Non-user (rebamipide was not co-prescribed during the follow-up period), Continuous-user (rebamipide was co-prescribed from t0 with the same number of tablets as NSAIDs), and Irregular-user (neither Non-user nor Continuous-user). Conditional logistic regression analysis was conducted to estimate each category’s odds ratio compared to non-users. Findings Of 67,561 individuals who met the inclusion criteria, 215 cases and 1,516 controls were selected. Compared with that of Non-users, the odds ratios and 95% confidence interval were 0.65 (0.44–0.96) for Continuous-users and 2.57 (1.73–3.81) for Irregular-users. Conclusions Continuous co-prescription of rebamipide significantly reduced the risk of upper gastrointestinal bleeding in an Asian cohort of new users of NSAIDs with osteoarthritis or low back pain without risk factors other than age.

show abstract

Clinical evaluation of hip joint diseases: total hip arthroplasty to support patients’ quality of life

Cited by 7 publications

References 77 publications

Life Course Epidemiology of Hip Osteoarthritis in Japan

Life Course Epidemiology of Hip Osteoarthritis in Japan

Interaction between physical activity and sleep quality at midterm after total knee arthroplasty: a Japanese retrospective cohort study

Continuous co-prescription of rebamipide prevents upper gastrointestinal bleeding in NSAID use for orthopaedic conditions: A nested case-control study using the LIFE Study database

Contact Info

Product

Resources

About